The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review

In this narrative review, we analyze pre-registration and post-marketing data concerning hepatotoxicity of all disease-modifying therapies (DMTs) available for the treatment of relapsing-remitting multiple sclerosis, including beta interferon, glatiramer acetate, fingolimod, teriflunomide, dimethyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Biolato, Marco, Bianco, Assunta, Lucchini, Matteo, Gasbarrini, Antonio, Mirabella, Massimiliano, Grieco, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354931/
https://www.ncbi.nlm.nih.gov/pubmed/34319570
http://dx.doi.org/10.1007/s40263-021-00842-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354931/
https://www.ncbi.nlm.nih.gov/pubmed/34319570
http://dx.doi.org/10.1007/s40263-021-00842-9

Ejemplares similares